Dow Up0.59% Nasdaq Up0.75%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
7.00 0.00(0.00%) 4:00PM EDT
CompetitorsGet Competitors for:
Direct Competitor Comparison 
SNSSAZNPVT1PFEIndustry
Market Cap:423.09M93.01BN/A190.54B167.86M
Employees:3251,500N/A77,70059.00
Qtrly Rev Growth (yoy):0.000.04N/A-0.020.18
Revenue (ttm): 7.96M25.96BN/A50.33B10.77M
Gross Margin (ttm):1.000.80N/A0.820.51
EBITDA (ttm):-35.93M8.66BN/A21.83B-9.40M
Operating Margin (ttm): -4.510.24N/A0.32-1.41
Net Income (ttm):-41.14M2.02BN/A10.37BN/A
EPS (ttm):-0.701.63N/A3.22-0.24
P/E (ttm):N/A45.15N/A9.3327.78
PEG (5 yr expected):N/A27.83N/A4.22N/A
P/S (ttm):53.143.59N/A3.7716.00
 
AZN = AstraZeneca PLC
Pvt1 = Corden Pharma Switzerland LLC (privately held)
PFE = Pfizer Inc.
Industry = Biotechnology

Biotechnology Companies Ranked By Sales 
CompanySymbolPriceChangeMarket CapP/E
Amgen Inc.AMGN139.330.01105.84B22.62
Genentech, Inc.Private - View Profile
Biogen Idec Inc.BIIB326.880.0277.19B40.66
Genzyme CorporationPrivate - View Profile
Merck Serono S.A.Private - View Profile
Gilead Sciences Inc.GILD104.760.04158.36B38.80
MedImmune, L.L.C.Private - View Profile
Life Technologies CorporationPrivate - View Profile
Teva Pharmaceutical Industries LimitedTEVA52.230.0244.59B32.26
Sandoz International GmbHPrivate - View Profile
 
View Biotechnology Industry Center

Generic Drugmakers Ranked by Sales 
CompanySymbolPriceChangeMarket CapP/E
Actavis plcACT238.760.0263.09BN/A
Ranbaxy Laboratories LimitedPrivate - View Profile
Mylan, Inc.MYL47.960.0317.94B29.96
Pfizer Inc.PFE30.050.00190.54B9.33
Johnson & JohnsonJNJ105.880.01298.61B20.25
GlaxoSmithKline plcGSK47.300.01113.61B13.45
SanofiSNY56.180.00147.43B28.84
Novartis AGNVS94.380.00228.99B24.08
Roche Holding AGRHHBY37.480.01254.67B20.86
AstraZeneca PLCAZN73.64-0.0093.01B45.15
 
View Biotechnology Industry Center

Drugmakers Ranked By Sales 
CompanySymbolPriceChangeMarket CapP/E
Abbott LaboratoriesABT42.900.0064.51B28.06
Bristol-Myers Squibb CompanyBMY51.150.0284.80B29.57
 
View Biotechnology Industry Center

 
News on Direct Competitors 

Currency in USD.